{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:04:48Z","timestamp":1787321088505,"version":"build-2736575974"},"reference-count":77,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","sempedneurjnl.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.spen.2017.04.003","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T18:01:10Z","timestamp":1491588070000},"page":"116-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Pediatric Myasthenia Gravis"],"prefix":"10.1016","volume":"24","author":[{"given":"Jason H.","family":"Peragallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2017.04.003_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-2004-829591","article-title":"Autoimmune myasthenia gravis in childhood","volume":"24","author":"Andrews","year":"2004","journal-title":"Semin Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0161-6420(99)00138-4","article-title":"The natural history and ophthalmic involvement in childhood myasthenia gravis at the Hospital for Sick Children","volume":"107","author":"Mullaney","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.spen.2017.04.003_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jneuroim.2008.06.026","article-title":"Congenital myasthenic syndromes in childhood: Diagnostic and management challenges","volume":"201-202","author":"Kinali","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.spen.2017.04.003_bib4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1474-4422(14)70201-7","article-title":"Congenital myasthenic syndromes: Pathogenesis, diagnosis, and treatment","volume":"14","author":"Engel","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2474-5-42","article-title":"Myasthenia gravis and pregnancy: Clinical implications and neonatal outcome","volume":"5","author":"T\u00e9llez-Zenteno","year":"2004","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.spen.2017.04.003_bib6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1542\/peds.45.3.488","article-title":"Neonatal myasthenia gravis: Report of two cases and review of the literature","volume":"45","author":"Namba","year":"1970","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2017.04.003_bib7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/WCO.0b013e32833c32af","article-title":"Acquired myasthenia gravis in childhood","volume":"23","author":"Evoli","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib8","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/MOP.0b013e328365ad16","article-title":"Update on juvenile myasthenia gravis","volume":"25","author":"Liew","year":"2013","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.spen.2017.04.003_bib9","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/0883073808325651","article-title":"Juvenile myasthenia gravis: Three case reports and a literature review","volume":"24","author":"Gadient","year":"2009","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2010.10.020","article-title":"Clinical and biological heterogeneity of autoimmune myasthenia gravis","volume":"231","author":"Pal","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.spen.2017.04.003_bib11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jns.2014.09.013","article-title":"Double seronegative myasthenia gravis with low density lipoprotein-4 (LRP4) antibodies presenting with isolated ocular symptoms","volume":"346","author":"Tsivgoulis","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.spen.2017.04.003_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.spen.2017.04.003_bib13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/088307380001501113","article-title":"Myasthenia gravis and associated autoimmune diseases in childhood","volume":"15","author":"Tsao","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib14","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/1352458511431728","article-title":"Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: Ten new aquaporin-4 antibody positive cases and a review of the literature","volume":"18","author":"Jarius","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.spen.2017.04.003_bib15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.pediatrneurol.2014.12.006","article-title":"An increase in circulating B cell-activating factor in childhood-onset ocular myasthenia gravis","volume":"52","author":"Motobayashi","year":"2015","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib16","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.pediatrneurol.2016.06.013","article-title":"Usefulness of circulating B-cell-activating factor in serial monitoring in childhood-onset ocular myasthenia gravis","volume":"63","author":"Motobayashi","year":"2016","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000279334","article-title":"The incidence of myasthenia gravis: A systematic literature review","volume":"34","author":"McGrogan","year":"2010","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.spen.2017.04.003_bib18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in myasthenia gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib19","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1212\/WNL.42.10.1888","article-title":"The epidemiology of myasthenia gravis in central and western Virginia","volume":"42","author":"Phillips","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.04.003_bib20","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/jnnp.2006.100545","article-title":"Clinical and serological study of myasthenia gravis in HuBei Province, China","volume":"78","author":"Zhang","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.spen.2017.04.003_bib21","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1212\/WNL.37.12.1854","article-title":"Myasthenia gravis: Population differences in disease expression and acetylcholine receptor antibody titers between Chinese and Caucasians","volume":"37","author":"Chiu","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.04.003_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/CND.0b013e318253a48e","article-title":"Juvenile myasthenia gravis: A twenty-year experience","volume":"14","author":"Castro","year":"2013","journal-title":"J Clin Neuromusc Dis"},{"key":"10.1016\/j.spen.2017.04.003_bib23","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00417-014-2759-3","article-title":"Associated morbidity of pediatric ptosis\u2014a large, community based case-control study","volume":"252","author":"Nemet","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.spen.2017.04.003_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ajo.2010.05.002","article-title":"Visual and systemic outcomes in pediatric ocular myasthenia gravis","volume":"150","author":"Pineles","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.spen.2017.04.003_bib25","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.ophtha.2007.10.022","article-title":"Long-term outcomes of pediatric ocular myasthenia gravis","volume":"115","author":"Ortiz","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.spen.2017.04.003_bib26","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.ophtha.2015.03.010","article-title":"Prognosis of ocular myasthenia gravis: Retrospective multicenter analysis","volume":"122","author":"Nagia","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.spen.2017.04.003_bib27","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ana.410140504","article-title":"Prognosis of ocular myasthenia","volume":"14","author":"Bever","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib28","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/S0161-6420(03)00460-3","article-title":"Childhood ocular myasthenia gravis","volume":"110","author":"Kim","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.spen.2017.04.003_bib29","first-page":"181","article-title":"Major review: the clinical spectrum of pediatric myasthenia gravis: blepharoptosis, ophthalmoplegia and strabismus. A report of 14 cases","volume":"17","author":"McCreery","year":"2002","journal-title":"Binocul Vis Strabismus Q"},{"key":"10.1016\/j.spen.2017.04.003_bib30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: Recommendations for clinical research standards. Task force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.04.003_bib31","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/S0161-6420(99)00709-5","article-title":"An ice test for the diagnosis of myasthenia gravis","volume":"106","author":"Golnik","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.spen.2017.04.003_bib32","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1212\/WNL.37.8.1383","article-title":"Ice pack test for myasthenia gravis","volume":"37","author":"Sethi","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.04.003_bib33","first-page":"288","article-title":"The sleep test for myasthenia gravis. A safe alternative to Tensilon","volume":"11","author":"Odel","year":"1991","journal-title":"J Clin Neuroophthalmol"},{"key":"10.1016\/j.spen.2017.04.003_bib34","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0161-6420(00)00458-9","article-title":"The ice test versus the rest test in myasthenia gravis","volume":"107","author":"Kubis","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.spen.2017.04.003_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-0033-1364181","article-title":"Juvenile myasthenia gravis: Recommendations for diagnostic approaches and treatment","volume":"45","author":"Della Marina","year":"2014","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.spen.2017.04.003_bib36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.nmd.2005.01.010","article-title":"Serological follow-up in juvenile myasthenia: Clinical and acetylcholine receptor antibody status of patients followed for at least 2 years","volume":"15","author":"Anlar","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2017.04.003_bib37","doi-asserted-by":"crossref","first-page":"e939","DOI":"10.1542\/peds.2013-0814","article-title":"Clinical characteristics of pediatric myasthenia: A surveillance study","volume":"132","author":"VanderPluym","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2017.04.003_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mus.20069","article-title":"Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients","volume":"30","author":"Zhou","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.spen.2017.04.003_bib39","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.nmd.2013.07.010","article-title":"Muscle specific kinase autoimmune myasthenia gravis in children: A case series","volume":"23","author":"Skjei","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2017.04.003_bib40","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.spen.2017.04.003_bib41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib42","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s00415-015-7963-5","article-title":"Myasthenia gravis: A clinical-immunological update","volume":"263","author":"Binks","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib43","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1469-8749.2008.02038.x","article-title":"Neurophysiological strategies for the diagnosis of disorders of the neuromuscular junction in children","volume":"50","author":"Pitt","year":"2008","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/088307389300800422","article-title":"Tests for juvenile myasthenia gravis: Comparative diagnostic yield and prediction of outcome","volume":"8","author":"Afifi","year":"1993","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib45","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S1388-2457(00)00307-2","article-title":"SFEMG in ocular myasthenia gravis diagnosis","volume":"111","author":"Padua","year":"2000","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.spen.2017.04.003_bib46","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/mus.25012","article-title":"Stimulated jitter analysis for the evaluation of neuromuscular junction disorders in children","volume":"53","author":"Verma","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.spen.2017.04.003_bib47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF01959485","article-title":"Early-onset myasthenia gravis: Clinical characteristics and response to therapy","volume":"150","author":"Batocchi","year":"1990","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.spen.2017.04.003_bib48","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/archneur.60.2.243","article-title":"Development of generalized disease at two years in patients with ocular myasthenia gravis","volume":"60","author":"Kupersmith","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib49","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1007\/s00415-009-5120-8","article-title":"Ocular myasthenia gravis: Treatment successes and failures in patients with long-term follow-up","volume":"256","author":"Kupersmith","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib50","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/mus.24769","article-title":"Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial","volume":"53","author":"Benatar","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.spen.2017.04.003_bib51","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-0404.2006.00646.x","article-title":"Myasthenia gravis in children: A longitudinal study","volume":"114","author":"Ashraf","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.spen.2017.04.003_bib52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pediatrneurol.2012.07.008","article-title":"Management of juvenile myasthenia gravis","volume":"48","author":"Ionita","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib53","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.50.6.1778","article-title":"A randomized double-blind trial of prednisone alone or with azathioprine in myasthenia gravis: Myasthenia Gravis Study Group","volume":"50","author":"Palace","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.04.003_bib54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11940-011-0151-8","article-title":"Treatment of ocular myasthenia gravis","volume":"14","author":"Haines","year":"2012","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib55","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1067\/S0022-3476(03)00300-7","article-title":"Successful treatment of refractory myasthenia gravis using rituximab: A pediatric case report","volume":"143","author":"Wylam","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.spen.2017.04.003_bib56","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jns.2009.02.357","article-title":"Rituximab for myasthenia gravis: Three case reports and review of the literature","volume":"280","author":"Stieglbauer","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.spen.2017.04.003_bib57","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.pediatrneurol.2012.05.017","article-title":"Rituximab in severe seronegative juvenile myasthenia gravis: Review of the literature","volume":"47","author":"Koul","year":"2012","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib58","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaneurol.2016.4190","article-title":"Durability of the rituximab response in acetylcholine receptor autoantibody-positive myasthenia gravis","volume":"74","author":"Robeson","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib59","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/mus.21640","article-title":"Mycophenolate mofetil in AChR-antibody-positive myasthenia gravis: Outcomes in 102 patients","volume":"41","author":"Hehir","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.spen.2017.04.003_bib60","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1212\/01.wnl.0000312373.67493.7f","article-title":"A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis","volume":"71","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.04.003_bib61","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/01.wnl.0000312374.95186.cc","article-title":"An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis","volume":"71","author":"Sanders","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.04.003_bib62","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.0000000000002405","article-title":"Myasthenia gravis exacerbation after discontinuing mycophenolate","volume":"86","author":"Oskarsson","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.04.003_bib63","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jns.2010.09.033","article-title":"Five-year follow-up with low-dose tacrolimus in patients with myasthenia gravis","volume":"300","author":"Minami","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.spen.2017.04.003_bib64","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.braindev.2012.06.012","article-title":"Effective treatment of a 13-year-old boy with steroid-dependent ocular myasthenia gravis using tacrolimus","volume":"35","author":"Mori","year":"2013","journal-title":"Brain Dev"},{"key":"10.1016\/j.spen.2017.04.003_bib65","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1212\/01.wnl.0000256698.69121.45","article-title":"IV immunoglobulin in patients with myasthenia gravis","volume":"68","author":"Zinman","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.04.003_bib66","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0887-8994(99)00112-5","article-title":"High-dose intravenous immunoglobulin therapy in juvenile myasthenia gravis","volume":"22","author":"Selcen","year":"2000","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib67","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.tmrv.2007.01.002","article-title":"Guidelines on the use of intravenous immune globulin for neurologic conditions","volume":"21","author":"Feasby","year":"2007","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.spen.2017.04.003_bib68","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamaneurol.2014.17","article-title":"Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis","volume":"71","author":"Liew","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib69","first-page":"CD002277","article-title":"Intravenous immunoglobulin for myasthenia gravis","volume":"12","author":"Gajdos","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.spen.2017.04.003_bib70","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2017.04.003_bib71","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.spen.2017.04.003_bib72","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: Subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib73","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pediatrneurol.2012.02.025","article-title":"Childhood-onset myasthenia gravis with thymoma","volume":"46","author":"Nikolic","year":"2012","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2017.04.003_bib74","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.nmd.2013.09.013","article-title":"Outcome of children with acetylcholine receptor (AChR) antibody positive juvenile myasthenia gravis following thymectomy","volume":"24","author":"Heng","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2017.04.003_bib75","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.spen.2017.04.003_bib76","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3928\/01913913-20091104-07","article-title":"Prolonged constant eye misalignment leads to failure to develop binocular vision in childhood ocular myasthenia gravis","volume":"46","author":"Emoto","year":"2009","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.spen.2017.04.003_bib77","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/WNO.0b013e318280d630","article-title":"Long-term follow-up of strabismus surgery for patients with ocular myasthenia gravis","volume":"33","author":"Peragallo","year":"2013","journal-title":"J Neuroophthalmol"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909117300633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909117300633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T05:09:46Z","timestamp":1658898586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909117300633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1071909117300633"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2017.04.003","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Myasthenia Gravis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2017.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}